Literature DB >> 16857242

Modulation of cancer pathways by inhibitors of guanylate metabolism.

Edith Oláh1, Szabolcs Kökény, János Papp, Anikó Bozsik, Márton Keszei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16857242     DOI： 10.1016/j.advenzreg.2006.01.002

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN： 0065-2571


× No keyword cloud information.
  5 in total

Review 1.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

2.  Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.

Authors:  F Volpin; J Casaos; J Sesen; A Mangraviti; J Choi; N Gorelick; J Frikeche; T Lott; R Felder; S J Scotland; T S K Eisinger-Mathason; H Brem; B Tyler; N Skuli
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

Review 3.  The dynamic determinants of reaction specificity in the IMPDH/GMPR family of (β/α)(8) barrel enzymes.

Authors:  Lizbeth Hedstrom
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-02-15       Impact factor: 8.250

4.  Newer human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.

Authors:  Chetan P Shah; Prashant S Kharkar
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

5.  Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.

Authors:  Ana Trapero; Angela Pacitto; Vinayak Singh; Mohamad Sabbah; Anthony G Coyne; Valerie Mizrahi; Tom L Blundell; David B Ascher; Chris Abell
Journal:  J Med Chem       Date:  2018-03-23       Impact factor: 7.446
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.